Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Microrna profiling analysis of differences between the melanoma of young adults and older adults.

Jukic DM, Rao UN, Kelly L, Skaf JS, Drogowski LM, Kirkwood JM, Panelli MC.

J Transl Med. 2010 Mar 19;8:27. doi: 10.1186/1479-5876-8-27.

2.

Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.

Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG.

Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31.

PMID:
23111773
3.

Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.

Venkatesan N, Kanwar J, Deepa PR, Khetan V, Crowley TM, Raguraman R, Sugneswari G, Rishi P, Natarajan V, Biswas J, Krishnakumar S.

PLoS One. 2016 Jan 26;11(1):e0146128. doi: 10.1371/journal.pone.0146128. eCollection 2016.

4.

MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling.

Glud M, Klausen M, Gniadecki R, Rossing M, Hastrup N, Nielsen FC, Drzewiecki KT.

J Invest Dermatol. 2009 May;129(5):1219-24. doi: 10.1038/jid.2008.347. Epub 2008 Nov 13.

5.

MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.

Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A, Gutzmer R.

Int J Cancer. 2010 Jun 1;126(11):2553-62. doi: 10.1002/ijc.24960.

6.

Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.

Estep M, Armistead D, Hossain N, Elarainy H, Goodman Z, Baranova A, Chandhoke V, Younossi ZM.

Aliment Pharmacol Ther. 2010 Aug;32(3):487-97. doi: 10.1111/j.1365-2036.2010.04366.x. Epub 2010 May 22.

7.

Expression of microRNAs in basal cell carcinoma.

Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.

Br J Dermatol. 2012 Oct;167(4):847-55. doi: 10.1111/j.1365-2133.2012.11022.x. Epub 2012 Aug 20.

PMID:
22540308
8.

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.

Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY.

Breast Cancer Res Treat. 2012 Aug;134(3):1081-93. doi: 10.1007/s10549-012-2034-4. Epub 2012 Apr 4.

PMID:
22476851
9.

MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.

Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY.

J Surg Oncol. 2012 Feb;105(2):175-82. doi: 10.1002/jso.22066. Epub 2011 Aug 22.

PMID:
21882196
10.

Differential profiles of microRNAs in retinoblastoma cell lines of different proliferation and adherence patterns.

Jo DH, Kim JH, Park WY, Kim KW, Yu YS, Kim JH.

J Pediatr Hematol Oncol. 2011 Oct;33(7):529-33. doi: 10.1097/MPH.0b013e318228280a.

PMID:
21941147
11.

MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer.

Huang ZM, Yang J, Shen XY, Zhang XY, Meng FS, Xu JT, Zhang BF, Gao HJ.

J Dig Dis. 2009 Aug;10(3):188-94. doi: 10.1111/j.1751-2980.2009.00384.x.

PMID:
19659786
12.

Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.

Oncol Rep. 2010 Jun;23(6):1625-33.

PMID:
20428818
13.

Profiling of molecular pathways regulated by microRNA 601.

Ohdaira H, Nakagawa H, Yoshida K.

Comput Biol Chem. 2009 Dec;33(6):429-33. doi: 10.1016/j.compbiolchem.2009.09.003. Epub 2009 Oct 2.

PMID:
19889580
14.

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, FoĆ  R, Macino G.

Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.

PMID:
19760605
15.

Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues.

Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, Jurisica I, Penn LZ, Liu FF.

Lab Invest. 2009 May;89(5):597-606. doi: 10.1038/labinvest.2009.12. Epub 2009 Mar 16. Erratum in: Lab Invest. 2009 Jun;89(6):726. Waldron, Levi [added].

16.

[Differential expression profile of microRNA between hyperplastic scar and normal skin].

Ning P, Liu DW, Mao YG, Peng Y, Lin ZW, Liu DM.

Zhonghua Yi Xue Za Zhi. 2012 Mar 13;92(10):692-4. Chinese.

PMID:
22781298
17.

Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.

Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L.

Int J Mol Med. 2011 Sep;28(3):327-36. doi: 10.3892/ijmm.2011.714. Epub 2011 Jun 1.

PMID:
21637912
18.

Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.

Latchana N, Regan K, Howard JH, Aldrink JH, Ranalli MA, Peters SB, Zhang X, Gru A, Payne PRO, Suarez-Kelly LP, Carson WE 3rd.

J Surg Res. 2016 Oct;205(2):350-358. doi: 10.1016/j.jss.2016.06.085. Epub 2016 Jul 4.

19.

[MicroRNAs expression in normal and dissected aortic tissue].

Hu ZY, Luo JF, Zhong SL, Xue L, Chen YF, Fan RX.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 May;40(5):406-10. Chinese.

PMID:
22883092
20.

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.

Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY.

RNA. 2008 Nov;14(11):2348-60. doi: 10.1261/rna.1034808. Epub 2008 Sep 23.

Supplemental Content

Support Center